Moderna Inc
NASDAQ:MRNA

Watchlist Manager
Moderna Inc Logo
Moderna Inc
NASDAQ:MRNA
Watchlist
Price: 39.1601 USD -0.58%
Market Cap: 15.1B USD
Have any thoughts about
Moderna Inc?
Write Note

Gross Margin
Moderna Inc

78.4%
Current
66%
Average
63.9%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
78.4%
=
Gross Profit
4B
/
Revenue
5.1B

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
US
Moderna Inc
NASDAQ:MRNA
15.1B USD
78%
FR
Pharnext SCA
OTC:PNEXF
6T USD
0%
US
Abbvie Inc
NYSE:ABBV
310.2B USD
67%
US
Amgen Inc
NASDAQ:AMGN
142B USD
60%
US
Gilead Sciences Inc
NASDAQ:GILD
115B USD
78%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
101.6B USD
86%
US
Epizyme Inc
F:EPE
94.1B EUR
76%
AU
CSL Ltd
ASX:CSL
134.4B AUD
52%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.5B USD
87%
US
Seagen Inc
F:SGT
39.3B EUR
75%
NL
argenx SE
XBRU:ARGX
35.8B EUR
89%
Country US
Market Cap 15.1B USD
Gross Margin
78%
Country FR
Market Cap 6T USD
Gross Margin
0%
Country US
Market Cap 310.2B USD
Gross Margin
67%
Country US
Market Cap 142B USD
Gross Margin
60%
Country US
Market Cap 115B USD
Gross Margin
78%
Country US
Market Cap 101.6B USD
Gross Margin
86%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 134.4B AUD
Gross Margin
52%
Country US
Market Cap 78.5B USD
Gross Margin
87%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country NL
Market Cap 35.8B EUR
Gross Margin
89%
No Stocks Found

Moderna Inc
Glance View

Market Cap
15.1B USD
Industry
Biotechnology
Economic Moat
None

In the vibrant world of biotechnology, Moderna Inc. stands as a remarkable testament to the fusion of cutting-edge science and swift innovation. Founded in 2010 and based in Cambridge, Massachusetts, Moderna has crafted its niche in messenger RNA (mRNA) technology, pivoting the traditional paradigms of drug development. The company’s unique approach utilizes synthetic mRNA to direct cells in the body to produce proteins that can prevent, treat, or cure diseases. This innovative platform enables rapid testing and development of medicines across a wide array of therapeutic areas, from infectious diseases to oncology, leveraging its flexible technology to address significant unmet medical needs. Moderna’s story gained global prominence in the context of the COVID-19 pandemic, when its vaccine, one of the first to be authorized, became crucial in combatting the virus, highlighting the potential of mRNA technology on a global stage. Financially, Moderna’s business model is driven by a combination of strategic partnerships, robust research and development capabilities, and the commercialization of its mRNA products. The company collaborates extensively with government agencies, global health organizations, and biopharmaceutical enterprises to both advance its pipeline and maximize its market reach. Revenue is primarily generated through the sale of its COVID-19 vaccine, alongside income from grants and collaboration agreements. Moreover, Moderna continually invests in expanding its mRNA platform and portfolio, seeking long-term value creation by targeting diverse therapeutic areas such as rare diseases, autoimmune disorders, and personalized cancer vaccines. By reinvesting in innovation and scaling its manufacturing capabilities, Moderna is not just a quintessential biotech enterprise but a harbinger of a new era in medical science.

MRNA Intrinsic Value
48.5299 USD
Undervaluation 19%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
78.4%
=
Gross Profit
4B
/
Revenue
5.1B
What is the Gross Margin of Moderna Inc?

Based on Moderna Inc's most recent financial statements, the company has Gross Margin of 78.4%.